Phenytoin
Phenytoin is an anti-seizure medicine used to treat tonic-clonic (grand mal) seizures, complex partial (temporal lobe) seizures, and seizures during or after neurosurgery, and the injection is used for status epilepticus.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 40 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Phenytoin is an older standby seizure medicine, in use since about 1953 and available as a generic, for tonic-clonic (grand mal) and complex partial seizures, with an injection for status epilepticus (a prolonged seizure emergency); it is thought to calm misfiring nerve cells by blocking their sodium channels. Most people manage it, but sleepiness, dizziness, unsteadiness and jerky eye movements are common, especially when blood levels run high. Get help right away for a rash, blistering, mouth sores, or fever with swollen glands, which can signal a severe skin or allergic reaction. Never stop it suddenly, and expect blood tests, since a small dose change can raise levels sharply.
Clinical pearls
- Take antacids at a different time of day from phenytoin, since taking them together can lower its levels.
- Phenytoin can make oral contraceptives, apixaban, rivaroxaban and some statins less effective, so tell every prescriber you take it.
- Chronic heavy drinking can lower phenytoin levels and a single bout of drinking can raise them, unsettling seizure control.
- Chewable tablets and the oral suspension are not for once-daily dosing, and the suspension needs a proper measuring device.
Patient information guide A plain-language walkthrough of Phenytoin, written from its FDA label.
What Phenytoin is used for
▾
Phenytoin treats several seizure types, depending on the product.
- Oral phenytoin products: tonic-clonic (grand mal) seizures and psychomotor (temporal lobe) or complex partial seizures.
- Most oral capsules and chewable tablets, including Dilantin Infatabs and Phenytek: seizures during or following neurosurgery.
- Dilantin-125 and Phenytoin oral suspension: tonic-clonic and psychomotor seizures.
- Phenytoin Sodium Injection: generalized tonic-clonic status epilepticus and seizures during neurosurgery.
- Intravenous Phenytoin Sodium Injection: short-term substitute for oral phenytoin when oral use is not possible.
How Phenytoin works
▾
The exact mechanism is not established. Phenytoin is thought to block voltage-dependent sodium channels on nerve cell membranes. This reduces sustained, high-frequency nerve firing, which helps prevent seizures from spreading.
Phenytoin dosage
▾
Oral phenytoin is taken by mouth, generally in divided doses through the day. Some extended-release capsules may be switched to once daily if your prescriber decides it is appropriate. Chewable tablets and suspension are not for once-daily use.
- Chewable tablets (Dilantin Infatabs) can be chewed thoroughly or swallowed whole.
- Measure suspension with a calibrated device.
- The injection is given by healthcare professionals, usually by vein.
- Follow your prescriber and label for dose and missed-dose directions.
Dosing details from the FDA-approved label
From the Phenytoin prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Status epilepticus – adults (injection)
- Loading dose of 10 to 15 mg/kg administered slowly intravenously at a rate not exceeding 50 mg per minute
- Followed by maintenance doses of 100 mg orally or intravenously every 6 to 8 hours
- Maximum: Rate not exceeding 50 mg per minute
- Continuous monitoring of ECG, blood pressure and respiratory function is essential
- Status epilepticus – pediatric (injection)
- Loading dose of 15 to 20 mg/kg intravenously, injected slowly at a rate not exceeding 1 to 3 mg/kg/min or 50 mg per minute, whichever is slower
- Maximum: Rate not exceeding 1 to 3 mg/kg/min or 50 mg per minute, whichever is slower
- Continuous monitoring of ECG and blood pressure is essential
- Non-emergent loading dose – adults (injection)
- Loading dose of 10 to 15 mg/kg administered slowly, followed by maintenance doses of oral or intravenous phenytoin every 6 to 8 hours
- Maximum: Rate not exceeding 50 mg per minute
- Oral phenytoin should be used whenever possible; slower administration rates are recommended to minimize cardiovascular adverse reactions
- Non-emergent loading dose – pediatric (injection)
- Administered intravenously at a rate not exceeding 1 to 3 mg/kg/min (or 50 mg per minute, whichever is slower)
- Maximum: 1 to 3 mg/kg/min or 50 mg per minute, whichever is slower
- Oral phenytoin should be used whenever possible
- Adults with no previous treatment – divided daily dosage (extended capsules)
- One 100-mg extended phenytoin sodium capsule by mouth three times daily
- For most adults the satisfactory maintenance dosage is one capsule three to four times a day
- Maximum: Up to two capsules three times a day
- Adjust the dosage to suit individual requirements
- Adults – once-a-day dosage (extended capsules)
- If seizure control is established with divided doses of three 100-mg extended phenytoin sodium capsules daily, once-a-day dosage with 300 mg of extended phenytoin sodium capsules may be considered
- Only extended phenytoin sodium capsules are recommended for once-a-day dosing
- Pediatric patients (extended capsules)
- Starting dose 5 mg/kg/day in two to three equally divided doses, with dosage adjustments as necessary
- Maintenance dosage 4 mg/kg/day to 8 mg/kg/day
- Maximum: 300 mg daily
Read the label’s full dosing text
2 DOSAGE AND ADMINISTRATION • Adult starting dose in patients who have received no previous treatment is one 100 mg extended phenytoin sodium capsule three times a day, with dose adjustments as necessary. For most adults, the satisfactory maintenance dose will be one capsule three to four times a day. An increase, up to two capsules three times a day may be made, if necessary. ( 2.1 ) • Adult once-a-day dose: If seizure control is established with divided doses of three 100 mg extended phenytoin sodium capsules daily, once-a-day dosage with 300 mg extended phenytoin sodium capsules may be considered. ( 2.1 ) • Adult loading dose: reserved for patients in a clinic or hospital setting who require rapid steady-state serum levels and where intravenous administration is not desired. Refer to full prescribing information. ( 2.1 ) • Pediatric starting dose is 5 mg/kg/day in two to three equally divided doses, with dosage adjustments as necessary, up to a maximum of 300 mg daily. Maintenance dosage is 4 mg/kg/day to 8 mg/kg/day. ( 2.2 ) • Serum blood level determinations may be necessary for optimal dosage adjustments—the clinically effective serum total concentration is 10 mcg/mL to 20 mcg/mL (unbound phenytoin concentration is 1 mcg/mL to 2 mcg/mL). ( 2.3 ) 2.1 Adult Dosage Divided daily dosage: The recommended starting dose for adult patients who have received no previous treatment is one 100-mg extended phenytoin sodium capsule by mouth three times daily. Adjust the dosage to suit individual requirements up to a maximum of two capsules three times a day. For most adults, the satisfactory maintenance dosage will be one capsule three to four times a day. Once-a-day dosage: In adults, if seizure control is established with divided doses of three 100-mg extended phenytoin sodium capsules daily, once-a-day dosage with 300 mg of extended phenytoin sodium capsules may be considered. Studies comparing divided doses of 300 mg with a single daily dose of this quantity indicated absorption, peak serum levels, biologic half-life, difference between peak and minimum values, and urinary recovery were equivalent. Once-a-day dosage offers a convenience to the individual patient or to nursing personnel for institutionalized patients and is intended to be used only for patients requiring this amount of drug daily.
Excerpted — the section continues on the label. Read the full Dosage and Administration section on DailyMed →
Phenytoin side effects
▾
Nervous system effects are the most common, and they are usually dose-related.
Common side effects
- Nystagmus (involuntary eye movements)
- Ataxia (unsteady walking or poor balance)
- Slurred speech
- Decreased coordination
- Sleepiness
- Mental confusion
- Dizziness or headache
- Nausea and vomiting
- Gum overgrowth
When to get medical help
- Get help right away for a rash, blistering or peeling skin, or mouth sores. These can be signs of severe skin reactions.
- Call your doctor for fever, swollen glands, or facial swelling, with or without a rash. These can signal a serious allergic reaction (DRESS).
- Seek emergency care for swelling of the face, lips or airway.
- Report yellow skin or eyes, or signs of liver problems.
- Report new or worsening depression, unusual mood or behavior changes, or thoughts of self-harm.
- Seek help for a slow heartbeat or fainting. Slow heartbeat and cardiac arrest have been reported.
- Tell your doctor about unusual bruising, bleeding, or frequent infections, which can signal blood count problems.
- Do not stop suddenly. Abrupt withdrawal may trigger status epilepticus.
Phenytoin warnings and precautions
▾
- Do not stop suddenly. Abrupt withdrawal may cause status epilepticus.
- Severe skin reactions can be fatal. Stop at the first sign of a rash unless it is clearly not drug-related, and call your doctor.
- DRESS (multiorgan hypersensitivity), angioedema and liver injury have been reported.
- Slow heartbeat and cardiac arrest have been reported.
- Blood count problems and swollen lymph nodes can occur.
- Antiepileptic drugs can raise the risk of suicidal thoughts.
- Long-term use is linked to weaker bones and low vitamin D.
- Caution in porphyria.
Phenytoin interactions
▾
Phenytoin has many interactions because it is highly protein bound, has saturable metabolism, and strongly induces liver enzymes.
- Delavirdine: must not be combined, since it can cause loss of HIV treatment response.
- Antacids: can lower phenytoin absorption, so separate them.
- Azole antifungals, certain antidepressants, cimetidine, omeprazole: may raise phenytoin levels.
- Rifampin, carbamazepine, St. John's wort, chronic heavy alcohol use: may lower levels.
- Warfarin, blood thinners like apixaban and rivaroxaban, oral contraceptives, statins: may be affected.
- Valproate: risk of high ammonia.
- Tube feeding: can lower phenytoin levels.
Interactions listed in the FDA-approved label
From the Phenytoin prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
- Antiepileptic drugs (ethosuximide, felbamate, oxcarbazepine, methsuximide, topiramate): May increase phenytoin serum levels. Monitoring of phenytoin serum levels is recommended when a drug interaction is suspected; phenytoin dose adjustment may be required.
- Azoles (fluconazole, ketoconazole, itraconazole, miconazole, voriconazole): May increase phenytoin serum levels; phenytoin also impairs the efficacy of azoles. Adjustment of the dose may be required when adding or withdrawing these agents.
- Antacids (calcium carbonate, aluminum hydroxide, magnesium hydroxide): May decrease phenytoin serum levels and may affect absorption of phenytoin. Phenytoin and antacids should not be taken at the same time of day.
- Valproate (valproate sodium, valproic acid): May either increase or decrease phenytoin serum levels; concomitant use has been associated with an increased risk of valproate-associated hyperammonemia. Patients treated concomitantly should be monitored for signs and symptoms of hyperammonemia.
- Delavirdine: Phenytoin can substantially reduce the concentrations of delavirdine, which can lead to loss of virologic response and possible resistance. See Contraindications (4).
- Neuromuscular blocking agents (cisatracurium, pancuronium, rocuronium, vecuronium): Resistance to the neuromuscular blocking action has occurred in patients chronically administered phenytoin. Monitor patients closely for more rapid recovery from neuromuscular blockade than expected; infusion rate requirements may be higher.
- Warfarin: Increased and decreased PT/INR responses have been reported when phenytoin is coadministered with warfarin; warfarin may also increase phenytoin serum levels.
- Anticoagulants (apixaban, dabigatran, edoxaban, rivaroxaban): Their levels are decreased by phenytoin.
- Antiviral agents (fosamprenavir, nelfinavir, ritonavir): May decrease phenytoin serum levels; phenytoin with fosamprenavir alone may decrease the concentration of amprenavir.
- Enteral feeding/nutritional preparations: Patients receiving them have lower than expected phenytoin serum levels. Phenytoin should not be administered concomitantly with an enteral feeding preparation; more frequent serum phenytoin level monitoring may be necessary.
Read the label’s full interactions text
7 DRUG INTERACTIONS Phenytoin is extensively bound to plasma proteins and is prone to competitive displacement. Phenytoin is primarily metabolized by the hepatic cytochrome P450 enzyme CYP2C9 and to a lesser extent by CYP2C19, and is particularly susceptible to inhibitory drug interactions because it is subject to saturable metabolism. Inhibition of metabolism may produce significant increases in circulating phenytoin concentrations and enhance the risk of drug toxicity. Monitoring of phenytoin serum levels is recommended when a drug interaction is suspected. Phenytoin is a potent inducer of hepatic drug-metabolizing enzymes. Multiple drug interactions because of extensive plasma protein binding, saturable metabolism and potent induction of hepatic enzymes. (7.1 , 7.2) 7.1 Drugs that Affect Phenytoin Concentrations Table 2 includes commonly occurring drug interactions that affect phenytoin concentrations. However, this list is not intended to be inclusive or comprehensive. Individual prescribing information from relevant drugs should be consulted. The addition or withdrawal of these agents in patients on phenytoin therapy may require an adjustment of the phenytoin dose to achieve optimal clinical outcome.
Excerpted — the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Phenytoin
▾
- Allergy to phenytoin or other hydantoins is a contraindication.
- Prior liver injury from phenytoin is a contraindication.
- Pregnancy: risk of birth defects and fetal hydantoin syndrome. Newborns can have a bleeding disorder that may be prevented with vitamin K.
- Breastfeeding: phenytoin passes into milk.
- Older adults: may need lower or less frequent dosing.
- Liver or kidney disease, or low albumin: unbound drug levels are monitored.
- Decreased CYP2C9 function: may need lower doses.
Phenytoin overdose
▾
Too much phenytoin can cause nystagmus, unsteady walking, slurred speech, tremor, lethargy, blurred vision, nausea and vomiting. Severe cases can lead to coma, low blood pressure, slow heartbeat and cardiac arrest. There is no antidote, so treatment is supportive, and irreversible cerebellar damage has been reported.
How your body processes Phenytoin
▾
Phenytoin is mostly broken down by liver enzymes CYP2C9 and CYP2C19. This process can become saturated, so small dose increases may cause large jumps in blood levels. The average half-life is about 14 hours, and steady levels take at least 7 to 10 days. Chewable tablets peak at about 1.5 to 3 hours. Clearance is lower in older adults and can change during pregnancy.
How to store Phenytoin
▾
Store at 20° to 25°C (68° to 77°F) . Protect from moisture.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Supplements & herbs that interact with Phenytoin
224 supplements and herbal products have documented interactions with Phenytoin in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 9
- Moderate · 187
- Minor · 28
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Phenytoin has been associated with lower levels of 13 nutrients in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
- Higher significance · 5
- Moderate · 7
- Unrated · 1
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
Phenytoin: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Phenytoin — the kind of thing our pharmacy team would talk through with you at the counter.
What is phenytoin used for?
▾
Can I stop it if I feel fine?
▾
What side effects should I expect?
▾
Do I need to watch other medicines I take?
▾
Is phenytoin safe in pregnancy?
▾
Why might I need blood tests?
▾
Is Phenytoin available over the counter?
▾
When was Phenytoin first available?
▾
Who makes Phenytoin?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Phenytoin on HelloPharmacist
Phenytoin forms and strengths (how it comes)
Phenytoin is available in 5 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Phenytoin inactive ingredients by manufacturer.
Extended-release capsule
How this form is used
- Phenytek capsules are used for tonic-clonic and psychomotor seizures and for seizures during or following neurosurgery.
- Phenytek is usually started three times a day. Once-a-day dosing with the 300 mg capsule may be considered if seizures are controlled on divided doses.
- Phenytek adult loading doses are reserved for clinic or hospital settings.
Injection
How this form is used
- Phenytoin Sodium Injection is used for generalized tonic-clonic status epilepticus and for seizures during neurosurgery.
- Intravenous Phenytoin Sodium Injection can be substituted short-term for oral phenytoin.
- Phenytoin Sodium Injection is given with continuous monitoring of heart rhythm, blood pressure and breathing.
- Phenytoin Sodium Injection should ordinarily not be given into a muscle because of erratic absorption and local toxicity.
Chewable tablet
How this form is used
- Dilantin Infatabs and Phenytoin Infatabs are used for generalized tonic-clonic and complex partial seizures and for seizures during or following neurosurgery.
- Dilantin Infatabs are not for once-a-day dosing.
- Dilantin Infatabs can be chewed thoroughly before swallowing or swallowed whole.
Capsule
How this form is used
- Extended Phenytoin Sodium capsules are used for tonic-clonic and psychomotor seizures and for seizures during or following neurosurgery.
- Extended Phenytoin Sodium capsules are usually started three times a day, per the label.
- When switching between phenytoin products or between free acid and sodium salt forms, your doctor may check blood levels because drug content differs.
Oral suspension
How this form is used
- Dilantin-125 is used for tonic-clonic and psychomotor seizures.
- Dilantin-125 is for oral use only, not for injection.
- Dilantin-125 should be measured with a calibrated device, not a household spoon.
Phenytoin on the U.S. market: products, makers and brands
How Phenytoin appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
29 companies list 49 Phenytoin product records with the FDA, mostly as extended-release capsule, injection, chewable tablet; the earliest marketing or approval year on record is 1953. Brand names on the directory include Dilantin, Phenytek, Phenytoin Infatabs and 2 more; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (18) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Phenytoin is used (Medicaid data)
A general measure of how commonly Phenytoin is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Phenytoin is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Phenytoin prescribed? Of the 1,601 medications we measure, Phenytoin ranks #399 by Medicaid prescriptions — more than 75% of them.
Utilization by Phenytoin product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
phenytoin sodium 100 MG Extended Release Oral Capsule Most dispensed
Summed across the 9 of 137 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 855671
phenytoin 50 MG Chewable Tablet
Summed across the 4 of 24 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1313885
phenytoin 25 MG/ML Oral Suspension
Summed across the 5 of 20 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1313112
phenytoin sodium 30 MG Extended Release Oral Capsule
Summed across the 1 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 855869
phenytoin sodium 300 MG Extended Release Oral Capsule
Summed across the 2 of 6 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 855873
phenytoin sodium 200 MG Extended Release Oral Capsule
Summed across the 3 of 7 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 855861
5 ML phenytoin sodium 50 MG/ML Injection
Summed across the 1 of 10 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1670353
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Phenytoin, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 25 of 209 listed Phenytoin NDCs with Medicaid activity.
Compare Phenytoin products
A representative set of FDA-listed product records for Phenytoin — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Capsule | ||||
| 100 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 100 mg | Oral | Amneal Pharmaceuticals LLC | ANDA | View NDC → |
| 100 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 100 mg | Oral | Bryant Ranch Prepack | ANDA | View NDC → |
| 100 mg | Oral | Direct Rx | ANDA | View NDC → |
| 100 mg | Oral | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | View NDC → |
| 100 mg | Oral | Remedyrepack Inc. | ANDA | View NDC → |
| 💊Chewable tablet | ||||
| 50 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 50 mg | Oral | Major Pharmaceuticals | ANDA | View NDC → |
| 50 mg | Oral | NCS HealthCare of KY, LLC dba Vangard Labs × 2 listings | ANDA | View NDC → |
| 50 mg | Oral | Parke-Davis Div of Pfizer Inc | ANDA | View NDC → |
| 50 mg | Oral | Prasco Laboratories | ANDA | View NDC → |
| 50 mg | Oral | Remedyrepack Inc. | ANDA | View NDC → |
| 50 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 50 mg | Oral | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 💊Extended-release capsule | ||||
| 100 mg | Oral | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 100 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC × 2 listings | ANDA | View NDC → |
| 100 mg | Oral | AvPAK | ANDA | View NDC → |
| 100 mg | Oral | Coupler LLC | ANDA | View NDC → |
| 100 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 100 mg | Oral | Major Pharmaceuticals | ANDA | View NDC → |
| 300 mg | Oral | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 100 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 100 mg | Oral | Remedyrepack Inc. × 2 listings | ANDA | View NDC → |
| 100 mg | Oral | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 200 mg | Oral | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 300 mg | Oral | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 100 mg | Oral | Unichem Pharmaceuticals (USA), Inc. | ANDA | View NDC → |
| 💊Injection | ||||
| 50 mg/mL | Intramuscular, Intravenous | Acella Pharmaceuticals, LLC | ANDA | View NDC → |
| 50 mg/mL | Intramuscular, Intravenous | Henry Schein, Inc. × 2 listings | ANDA | View NDC → |
| 50 mg/mL | Intramuscular, Intravenous | HF Acquisition Co LLC, DBA HealthFirst × 2 listings | ANDA | View NDC → |
| 50 mg/mL | Intramuscular, Intravenous | Hikma Pharmaceuticals USA Inc. × 4 listings | ANDA | View NDC → |
| 50 mg/mL | Intramuscular, Intravenous | Medical Purchasing Solutions, LLC | ANDA | View NDC → |
| 50 mg/mL | Intramuscular, Intravenous | ProPharma Distribution | ANDA | View NDC → |
| 💊Oral suspension | ||||
| 125 mg/5 mL | Oral | American Health Packaging | ANDA | View NDC → |
| 125 mg/5 mL | Oral | Atlantic Biologicals Corp. | ANDA | View NDC → |
| 125 mg/5 mL | Oral | Mylan Pharmaceuticals Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 125 mg/5 mL | Oral | PAI Holdings, LLC dba PAI Pharma | ANDA | View NDC → |
| 125 mg/5 mL | Oral | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 125 mg/5 mL | Oral | Viatris Specialty LLC | NDA | View NDC → |
Showing 49 of 49 products — FDA National Drug Code Directory. See every product, package size and price: browse all 49 Phenytoin NDCs →
Phenytoin side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Phenytoin — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Phenytoin in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Phenytoin FDA approval history
How Phenytoin went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Phenytoin recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list 3 Phenytoin recalls since July 2021, covering 4 product listings. None of them is still listed as ongoing. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- Extended Phenytoin Sodium Capsules, USP, 100 mg, 100-count bottle, Distributed by Amneal Pharmaceuticals LLC Bridgewater, NJ, 08807, NDC# 65162-212-10 Lots: Lot # HM03221A, Exp. date 12/31/2023 FDA record D-0090-2024 →
- Extended Phenytoin Sodium Capsules, USP, 100 mg, Rx Only, 100 capsules per bottle, Distributed by: Amneal Pharmaceuticals LLC., Bridgewater, NJ 08807, NDC 65162-212-10. Lots: Lot # HL00721A, Exp. 12/2023 FDA record D-0876-2023 →
- Phenytoin Sodium Injection, USP, 250 mg/5 mL, NDC 42192-614-05, packaged in 10 x 5 mL vials per carton, NDC 42192-614-30, Rx only, Manufactured for: Acella Pharmaceuticals, LLC Alpharetta, GA 30005 Lots: Lot: E026A001 Exp. 06/2023 FDA record D-0070-2023 →
- Phenytoin Sodium Injection, USP 100 mg/2 mL, NDC 42192-614-02, packaged in 10 x 2 mL vials per carton, NDC 42192-614-10, Rx only, Manufactured for: Acella Pharmaceuticals, LLC Alpharetta, GA 30005 Lots: Lot: E025A001 Exp. 07/2023 FDA record D-0069-2023 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 8183 7 dose forms · 16 strengths
-
Dose form (SCDF) Cartridge RxCUI 1670368No current FDA listingClinical drug / strength (SCD) 2 ML phenytoin sodium 50 MG/MLRxCUI 855911 -
Dose form (SCDF) Chewable Tablet RxCUI 373433In current FDA listingsClinical drug / strength (SCD) 50 MGRxCUI 1313885 -
Dose form (SCDF) Extended Release Oral Capsule RxCUI 373435In current FDA listingsClinical drug / strength (SCD) sodium 100 MGRxCUI 855671sodium 200 MGRxCUI 855861sodium 30 MGRxCUI 855869sodium 300 MGRxCUI 855873 -
Dose form (SCDF) Injection RxCUI 1670350In current FDA listingsClinical drug / strength (SCD) 2 ML phenytoin sodium 50 MG/MLRxCUI 16703515 ML phenytoin sodium 50 MG/MLRxCUI 1670353 -
Dose form (SCDF) Oral Capsule RxCUI 373434In current FDA listingsClinical drug / strength (SCD) sodium 100 MGRxCUI 855675sodium 25 MGRxCUI 855936sodium 300 MGRxCUI 855945sodium 50 MGRxCUI 855946 -
Dose form (SCDF) Oral Suspension RxCUI 373438In current FDA listings -
Dose form (SCDF) Oral Tablet RxCUI 373432No current FDA listingClinical drug / strength (SCD) sodium 100 MGRxCUI 855930
Look up RxCUI 8183 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Phenytoin supply and shortage status
Whether Phenytoin is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
💵 What Phenytoin costs pharmacies (NADAC benchmark)
The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.
| Form | Strength | Pharmacy acquisition benchmark | |
|---|---|---|---|
| Capsule, Extended Release · Oral | 100 mg | $0.145 per capsule | NDC details & price history |
| Capsule, Extended Release · Oral | 300 mg | $2.10 per capsule | NDC details & price history |
| Capsule, Extended Release · Oral | 200 mg | $0.989 per capsule | NDC details & price history |
| Tablet, Chewable · Oral | 50 mg | $1.57–$1.58 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.
Phenytoin brand names
Phenytoin is sold under 5 brand names in the FDA directory — Dilantin, Phenytek, Phenytoin Infatabs, Dilantin Infatabs and others. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Phenytoin: manufacturers and labelers
29 companies list Phenytoin products with the FDA. By number of product records, the largest are Sun Pharmaceutical Industries, Inc., Hikma Pharmaceuticals USA Inc., Remedyrepack Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
…and 5 more on the FDA NDC directory.
Phenytoin drug class (RxNorm)
Phenytoin belongs to the Anti-epileptic Agent class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Phenytoin page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Greenstone LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →